Posted by - News Worthy -
on - Apr 20 -
Filed in - Impacts -
-
126 Views -
0 Comments -
0 Likes -
0 Reviews
In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
